Outcomes Rocket

Saul Marquez
  • 0,0 (0)
  • Medicin
  • Varje dag

At Outcomes Rocket, we are the shared knowledge hub for healthcare's toughest problems. Our goal is twofold and clear. To help inspire and guide our listeners to 1. Improve patient outcomes and 2. Experience business success in healthcare. Tune in to learn more!

  1. Changing the Clinical Value Equation in Orthopedic Care with Nic Aldrich, Vice President of Marketing at OrthAlign

    −1 d

    Changing the Clinical Value Equation in Orthopedic Care with Nic Aldrich, Vice President of Marketing at OrthAlign

    Orthopedic procedures are increasingly moving to ambulatory surgery centers, but many navigation technologies remain too expensive, complex, or inefficient for that setting. In this episode, Nic Aldrich, Vice President of Marketing at OrthAlign, discusses how handheld navigation technology is making precision orthopedic care more accessible. He explains how OrthAlign helps surgeons reduce variability, execute patient-specific plans, and bring advanced technology into total hip, knee, partial knee, and revision procedures. Nic also shares how the newly cleared Lantern ASC system was designed specifically for surgery centers, balancing accuracy with cost, speed, and ease of use. Tune in to learn how smaller, more efficient technologies are helping expand access to precision orthopedic care. Resources: Connect with and follow Nic Aldrich on LinkedIn. Follow OrthAlign on LinkedIn and explore their website. Learn more about the Lantern ASC system here.

    16 min
  2. Using AI to Strengthen Clinical Confidence in Procedures with Will Mauldin, Co-Founder and CEO of Rivanna Medical

    −3 d

    Using AI to Strengthen Clinical Confidence in Procedures with Will Mauldin, Co-Founder and CEO of Rivanna Medical

    AI in medtech is most valuable when it supports better clinical decisions, not when it replaces clinicians. In this episode, Alexis Anderson speaks with Will Mauldin, Co-Founder and CEO of Rivanna Medical, live from DeviceTalks Boston. Will explains how Rivanna is bringing AI-enabled imaging to clinical settings where providers have traditionally relied on blind or manual procedures, beginning with epidural anesthesia guidance and expanding into fracture detection. He shares how the company’s handheld spine guidance technology helps clinicians visualize the epidural space, use AI as a confirmation tool, and build confidence through consistent outcomes. Will also discusses broader medtech trends around AI, automation, connected devices, and robotics, along with funding challenges for mid-stage companies and Rivanna’s upcoming FDA milestones. Tune in and learn how AI-enabled imaging can improve safety, reduce bottlenecks, and support clinicians in high-demand care environments. Resources Connect and follow Will Mauldin on LinkedIn. Follow Rivanna Medical on LinkedIn and explore their website.

    12 min
  3. From Blind Biopsies to Precision: Reinventing Medical Imaging with Reza Khorasaninejad, Founder & CEO at LEADOPTIK

    −4 d

    From Blind Biopsies to Precision: Reinventing Medical Imaging with Reza Khorasaninejad, Founder & CEO at LEADOPTIK

    Lung cancer biopsies are still being done blind more often than you’d think, leading to costly diagnostic errors. In this episode, Reza Khorasaninejad, Founder & CEO at LEADOPTIK, discusses how advances in photonics and metasurface engineering are enabling highly miniaturized imaging systems for minimally invasive procedures. These innovations aim to address a major challenge in lung cancer biopsies: a lack of imaging guidance that can lead to significant diagnostic errors. Early clinical pilots across multiple sites are demonstrating strong performance, with one hospital already converting into a paying customer. Looking ahead, the company is partnering with Stanford Medicine to develop AI-driven decision support tools to further improve diagnostic accuracy. Tune in to learn how next-generation imaging and AI are changing that reality and helping physicians hit the right target the first time! Resources: Connect with and follow Reza Khorasaninejad on LinkedIn.Follow LEADOPTIK on LinkedIn and explore their website!

    12 min
  4. Building Bridges Across the Healthcare Ecosystem with Adam McMullin, CEO of AvaSure

    18 juni

    Building Bridges Across the Healthcare Ecosystem with Adam McMullin, CEO of AvaSure

    Healthcare technology only matters when it makes care safer, more accessible, and easier to deliver at scale. In this episode, Adam McMullin, CEO of AvaSure, joins Saul to discuss how virtual care, ambient AI, and smart room platforms are transforming inpatient care. He explains how AvaSure creates a “cocoon of safety” around patients and care teams through capabilities such as fall prevention, violence reduction, and expanded access to specialty care. Adam emphasizes that lasting technology adoption depends on thoughtful clinical workflow design, nurse engagement, open architecture, and strong partner ecosystems. He also shares leadership lessons on values alignment and explains why health systems are increasingly scaling smart room technologies to address financial pressures, workforce shortages, and efficiency demands. Tune in and learn how proven technology, trusted partnerships, and aligned leadership can help health systems deliver safer, smarter care. Resources: Connect with and follow Adam McMullin on LinkedIn. Follow AvaSure on LinkedIn and explore their website!

    16 min
  5. Creating the Future of MedTech Through Purpose with James Corbett, transformational MedTech CEO and Board Advisor

    17 juni

    Creating the Future of MedTech Through Purpose with James Corbett, transformational MedTech CEO and Board Advisor

    MedTech innovation succeeds when bold ideas are matched with disciplined execution, strong teams, and a clear purpose. In this episode, James Corbett, transformational MedTech CEO and Board Advisor, joins Saul to share the leadership lessons, operating principles, and industry changes that have shaped his decades-long career. Drawing on experience leading companies including Boston Scientific, ev3, Alphatec Spine, CathWorks, and AVITA Medical, Jim explains why people and purpose are the foundation of lasting success in healthcare. He discusses the future of MedTech, including the creation of new clinical categories, the importance of operational excellence, and the growing role of AI in leadership and business transformation. Jim also shares why many organizations are underutilizing AI, how his AI command center captures decades of operating knowledge, and why great people remain the ultimate competitive advantage. Tune in and learn how purpose-driven leadership, operational discipline, and AI-enabled execution can help shape the next generation of MedTech innovation! Resources: Connect with and follow James Corbett on LinkedIn. Explore Jim Corbett AI!

    32 min
  6. Policy Convergence and the Future of Pharma Value Creation with Steve Mather, Global Practice Lead of Strategy and Insight at Lumanity

    16 juni

    Policy Convergence and the Future of Pharma Value Creation with Steve Mather, Global Practice Lead of Strategy and Insight at Lumanity

    The future of market access belongs to organizations that plan years in advance. In this episode, Steve Mather, Global Practice Lead of Strategy and Insight at Lumanity, explains why pharmaceutical companies must prepare now for major market access changes coming in Europe and beyond. He highlights that Joint Clinical Assessments for rare disease assets, beginning in 2028, will require earlier planning, stronger governance, and more integrated evidence-generation strategies. Steve also discusses the complexity created by varying country-specific care pathways, limited comparators, and the growing importance of real-world evidence in rare disease development. Across policy shifts like JCA, IRA, MFN, and new European pharmaceutical legislation, the central message is clear: organizations that anticipate earlier will be better positioned to succeed. Tune in to hear how the future of rare disease market access is being reshaped, and why companies that prepare earlier will have a major strategic advantage! Resources: Connect with and follow Steve Mather on LinkedIn. Follow Lumanity on LinkedIn and explore their website! Learn more about this series we're doing with Lumanity here:  https://lumanity.com/commercialization-podcasts/

    25 min
  7. The Future of Medical Robotics: AI, Automation, and Global Growth with KUKA Robotics USA’s Silke Wendt, Global Marketing Medical Robotics, and Corey Ryan, Director of Medical Robotics

    15 juni

    The Future of Medical Robotics: AI, Automation, and Global Growth with KUKA Robotics USA’s Silke Wendt, Global Marketing Medical Robotics, and Corey Ryan, Director of Medical Robotics

    AI is transforming medical robotics, but not in the ways many people expect. In this episode, KUKA Robotics USA’s Silke Wendt, Global Marketing Medical Robotics, and Corey Ryan, Director of Medical Robotics, discuss how labor shortages, increasing quality demands, and growing interest in AI are shaping the future of medical robotics. While AI is becoming more prevalent in areas such as simulation, collision detection, and path planning, they emphasize that regulatory requirements limit its role in autonomous clinical decision-making. They also highlight KUKA's focus on quality, strategic partnerships, global expansion, and the development of new robotic platforms to support a growing range of medical applications. Tune in to hear how KUKA is navigating the opportunities and challenges of AI, automation, and innovation in healthcare robotics! Resources: Connect with and follow Silke Wendt on LinkedIn. Connect with and follow Corey Ryan on LinkedIn. Follow KUKA Robotics USA on LinkedIn and explore their website!

    6 min
  8. How Health Economics Drives Medtech Growth with Christian Howell, CEO of Cognito Therapeutics

    11 juni

    How Health Economics Drives Medtech Growth with Christian Howell, CEO of Cognito Therapeutics

    A non-invasive Alzheimer’s therapy is moving closer to patients, and it could reshape how brain health is treated. In this episode, Christian Howell, CEO of Cognito Therapeutics, joins Saul live at DeviceTalks Boston to discuss how the company is advancing a novel Alzheimer’s therapy that uses sensory stimulation through light, sound, and touch. He shares insights from Cognito’s HOPE study, the largest non-pharmacologic clinical trial in neurodegenerative disease, involving 673 participants across 70 sites. Christian explains why a strong evidence strategy is essential not only for regulatory approval but also for reimbursement, clinical adoption, and patient access. He also reflects on leadership lessons centered on service, humility, humor, and the importance of aligning stakeholders across the healthcare ecosystem to improve Alzheimer’s care. Tune in to hear how Christian Howell and Cognito Therapeutics are working to bring new hope, stronger evidence, and a more accessible path forward for Alzheimer’s patients and families! Resources: Connect with and follow Christian Howell on LinkedIn. Follow Cognito Therapeutics on LinkedIn and explore their website.

    16 min
Visa alla (2 tn)

Trailer

Om

At Outcomes Rocket, we are the shared knowledge hub for healthcare's toughest problems. Our goal is twofold and clear. To help inspire and guide our listeners to 1. Improve patient outcomes and 2. Experience business success in healthcare. Tune in to learn more!

Information

  • Skapad av
    Saul Marquez
  • Aktiva år
    2017 - 2026
  • Avsnitt
    2 tn
  • Åldersgräns
    Barnvänligt
  • Copyright
    © Saul Marquez
  • Programmets webbplats
    Outcomes Rocket

Du kanske också gillar